Restaurateur and media personality Max Tucci discusses how his New York City restaurant, Tucci, is offering meals catering to ...

Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.

Scientists have uncovered a way to promote weight loss and improve blood sugar control without the unpleasant side effects of ...

Ohio’s decision to end GLP-1 coverage for state employees is unjustified and harmful, writes Dr. Leslie Pristas, president of ...

Emerging concerns link GLP-1 use, found in weight loss drugs like Wegovy/Ozempic and Mounjaro, to potential thyroid cancer ...

An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...

Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.

Hims & Hers continues to spend heavily on marketing to attract new customers. During the quarter, its marketing spending ...

It has been a rough few seasons for Novo Nordisk (NYSE:NVO) investors, as the company’s share price has tumbled some 60% over ...

Gibbs puts a patient's volume of food noise down to a mix of genetics, environment, socialisation and food availability. Too ...

Kilow, Saudi Arabia’s leading digital health and weight loss platform, is proud to announce the official launch of Kilow ...

WEIGHT-LOSS drugs can be a silver bullet for some trying to shed the pounds after years of failure with fad diets and exercise routines. But dodgy vendors selling potentially deadly fake jabs ...